Gene · 2118
Papers2,714
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
861 to 880 of 2,714
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Distinct Classes of Flavonoids and Epigallocatechin Gallate, Polyphenol Affects an Oncogenic Mutant p53 Protein, Cell Growth and Invasion in a TNBC Breast Cancer Cell Line. | Cells | 2021 | 33918387 | PubTator, text mining | PubMed |
| IP6-assisted CSN-COP1 competition regulates a CRL4-ETV5 proteolytic checkpoint to safeguard glucose-induced insulin secretion. | Nat Commun | 2021 | 33911083 | PubTator, text mining | PubMed |
| EHF enhances malignancy by modulating AKT and MAPK/ERK signaling in non‑small cell lung cancer cells. | Oncol Rep | 2021 | 33907840 | PubTator, text mining | PubMed |
| MicroRNA governs bistable cell differentiation and lineage segregation via a noncanonical feedback. | Mol Syst Biol | 2021 | 33890404 | PubTator, text mining | PubMed |
| Chelidonine Induces Apoptosis via GADD45a-p53 Regulation in Human Pancreatic Cancer Cells. | Integr Cancer Ther | 2021 | 33884928 | PubTator, text mining | PubMed |
| Retracted: Transcription activation of microRNA-25 by PEA3 augments progression of gastric cancer through suppressing SIK1. | Exp Physiol | 2021 | 33876502 | PubTator, text mining | PubMed |
| Identification of a novel subset of alveolar type 2 cells enriched in PD-L1 and expanded following pneumonectomy. | Eur Respir J | 2021 | 33863742 | PubTator, text mining | PubMed |
| Identification of X-chromosomal genes that drive sex differences in embryonic stem cells through a hierarchical CRISPR screening approach. | Genome Biol | 2021 | 33863351 | PubTator, text mining | PubMed |
| A pan-cancer transcriptome analysis of exitron splicing identifies novel cancer driver genes and neoepitopes. | Mol Cell | 2021 | 33861991 | PubTator, text mining | PubMed |
| CIC-DUX4 rearranged uterine cervix round-cell sarcoma exhibiting near-complete pathologic response following radiation and neoadjuvant chemotherapy: A case report. | Gynecol Oncol Rep | 2021 | 33850994 | PubTator, text mining | PubMed |
| Identification and analysis of spinal cord injury subtypes using weighted gene co-expression network analysis. | Ann Transl Med | 2021 | 33850863 | PubTator, text mining | PubMed |
| Narrative review: predicting future molecular and clinical profiles of prostate cancer in the United States. | Transl Androl Urol | 2021 | 33850790 | PubTator, text mining | PubMed |
| RNA-Associated Co-expression Network Identifies Novel Biomarkers for Digestive System Cancer. | Front Genet | 2021 | 33841514 | PubTator, text mining | PubMed |
| Molecular Mechanisms of Endocrine Resistance in Estrogen-Positive Breast Cancer. | Front Endocrinol (Lausanne) | 2021 | 33841325 | PubTator, text mining | PubMed |
| A calcineurin-mediated scaling mechanism that controls a K+-leak channel to regulate morphogen and growth factor transcription. | Elife | 2021 | 33830014 | PubTator, text mining | PubMed |
| The MEK1/2 Pathway as a Therapeutic Target in High-Grade Serous Ovarian Carcinoma. | Cancers (Basel) | 2021 | 33803586 | PubTator, text mining | PubMed |
| Current Status of Management and Outcome for Patients with Ewing Sarcoma. | Cancers (Basel) | 2021 | 33801953 | PubTator, text mining | PubMed |
| A Scoping Review on Lipocalin-2 and Its Role in Non-Alcoholic Steatohepatitis and Hepatocellular Carcinoma. | Int J Mol Sci | 2021 | 33799862 | PubTator, text mining | PubMed |
| Comprehensive analysis of immune-related prognostic genes in the tumour microenvironment of hepatocellular carcinoma. | BMC Cancer | 2021 | 33789609 | PubTator, text mining | PubMed |
| PPP6C negatively regulates oncogenic ERK signaling through dephosphorylation of MEK. | Cell Rep | 2021 | 33789117 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2118/papers?page=44